تصفح حسب المؤلف "Mohamedali, Mohamed Gaafar"
-
Adding colchicine to tocilizumab in hospitalized patients with severe COVID-19 pneumonia: An open-label randomized controlled trial
Rahhal, Alaa; Najim, Mostafa; Aljundi, Amer Hussein; Mahfouz, Ahmed; Alyafei, Sumaya Mehdar; Awaisu, Ahmed; Habib, Mhd, Baraa; Obeidat, Ibrahim; Faisal, Mohanad Mohammed; Alanzi, Meshaal Ali; Nair, Arun Prabhakaran; Elhassan, Areeg; Al-Dushain, Abdullah; Abdelmajid, Alaaeldin Abdelmajid; Abdelgader, Ahmed Elfadil; Moursi, Ahmed Mahmoud Ahmed; Alharafsheh, Ahmad Eid Nazzal; Kamar, Mohd Ragheb Abou; Goravey, Wael; Omar, Amr Salah; Abukhattab, Mohammed; Khatib, Mohamad Yahya; Mohamedali, Mohamed Gaafar; AlMaslamani, Muna A. Rahman; Alemadi, Samar... more authors ... less authors ( Lippincott Williams and Wilkins , 2022 , Article)Introduction: Colchicine acts upstream in the cytokines cascade by inhibiting the nod-like receptor protein 3 (NLRP3) inflammasome while interleukin 6 (IL-6) receptor antagonists, such as tocilizumab, block the end result ... -
Comparative effectiveness and safety of direct-acting oral anticoagulants (DOACS) for the reduction of recurrent venous thromboembolism in cancer patients: A protocol for systematic review and network meta-analysis using a generalized pairwise modeling methodology.
Danjuma, Mohammed Ibn-Mas'ud; Mohamed, Mouhand F H; ElShafei, Mohamad Nabil; Fatima, Haajra; Shokri, Shaikha Al; Mohamed, Sara; Abubeker, Ibrahim Yusuf; Kartha, Anand; Elzouki, Abdel-Naser; Mohamedali, Mohamed Gaafar Hussein; Mahgboub, Yahya; Bidmos, Mubarak... more authors ... less authors ( Lippincott, Williams & Wilkins , 2020 , Article)There has been a significant improvement in both our understanding and therapeutic choices available to clinicians for the management of cancer associated thrombosis (CAT). Even with the recent publication of a systematic ...